Overview

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital Warts

Status:
Terminated
Trial end date:
2018-06-17
Target enrollment:
Participant gender:
Summary
This trial will be a phase 2, open-label, study to evaluate the safety, tolerability, and efficacy of VIR007 when administered topically for up to 60 days to adults between the ages of 18 to 65 years with a clinical diagnosis of external condylomata acuminata.
Phase:
Phase 2
Details
Lead Sponsor:
ViroXis Corporation
Collaborator:
Progressive Clinical Research